Overcoming hurdles: measurement of health-related outcomes associated with national level medicines usage in Ireland

Public discourse on medicine provision predominantly focuses on overall expenditure. However, current literature suggests measurement of alternative indicators can provide a method to benchmark or ameliorate medicine provision. Previous research has investigated the viability of using health-related...

Full description

Saved in:
Bibliographic Details
Published inDrugs in Context Vol. 9; pp. 1 - 6
Main Authors O'Brien, Gary L, McAlister, Muireann, Byrne, Stephen, Gallagher, James
Format Journal Article
LanguageEnglish
Published BioExcel Publishing Ltd 22.05.2020
Subjects
drug utilisation
health economics
life years gained
number of patients treated
pharmacoeconomics
quality-adjusted life years
Online AccessGet full text

Cover

More Information
Summary:Public discourse on medicine provision predominantly focuses on overall expenditure. However, current literature suggests measurement of alternative indicators can provide a method to benchmark or ameliorate medicine provision. Previous research has investigated the viability of using health-related outcome metrics, such as the number of patients treated, quality-adjusted life-year gain and life-year gain, to provide macro-level estimates on medicines’ societal contributions. This editorial provides an overview of the evolving healthcare landscape surrounding medicine usage estimation and valuation in Ireland and offers recommendations on how improved methods of measuring health-related outcomes may help ameliorate efficiencies and the sustainability of a healthcare system.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:1745-1981
1740-4398
1740-4398
DOI:10.7573/dic.2020-4-2